Profund Advisors LLC Has $13.83 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Profund Advisors LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,931 shares of the medical equipment provider’s stock after selling 1,339 shares during the quarter. Profund Advisors LLC’s holdings in Intuitive Surgical were worth $13,833,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Tobam lifted its holdings in shares of Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC purchased a new position in shares of Intuitive Surgical during the second quarter valued at $27,000. Greykasell Wealth Strategies Inc. acquired a new position in Intuitive Surgical during the third quarter valued at $27,000. Princeton Global Asset Management LLC purchased a new stake in Intuitive Surgical in the 2nd quarter worth about $30,000. Finally, Guerra Advisors Inc purchased a new stake in Intuitive Surgical in the 3rd quarter worth about $37,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ISRG. Barclays set a $712.00 target price on Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, January 26th. Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research note on Friday, January 23rd. Sanford C. Bernstein increased their target price on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Truist Financial boosted their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Finally, Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $617.23.

Intuitive Surgical Stock Up 2.5%

Shares of ISRG opened at $488.15 on Monday. The firm has a market cap of $173.36 billion, a price-to-earnings ratio of 61.87, a price-to-earnings-growth ratio of 3.79 and a beta of 1.65. The company’s fifty day moving average is $549.63 and its 200-day moving average is $510.60. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. During the same period in the prior year, the company posted $2.21 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the transaction, the executive vice president directly owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. This trade represents a 81.80% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 230 shares of the company’s stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $532.61, for a total value of $122,500.30. The SEC filing for this sale provides additional information. Insiders have sold a total of 70,011 shares of company stock worth $38,858,275 in the last 90 days. Company insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.